VANGUARD GROUP INC

Holdings History for Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Symbol: INMB on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,494,240	957,846	+81,554	+9.3%	$1.56	Q4 2025
30 Sep 2025	0%	+0%	$1,813,924	876,292	+28,541	+3.4%	$2.07	Q3 2025
30 Jun 2025	0%	+0%	$1,958,305	847,751	+21,138	+2.6%	$2.31	Q2 2025
31 Mar 2025	0%	+0%	$6,455,848	826,613	+88,412		$7.81	Q1 2025
31 Dec 2024	0%	+0%	$3,447,399	738,201	+17,489	+2.4%	$4.67	Q4 2024
30 Sep 2024	0%	+0%	$3,884,637	720,712	+92,413	+15%	$5.39	Q3 2024
30 Jun 2024	0%	+0%	$5,541,597	628,299	+86,970	+16%	$8.82	Q2 2024
31 Mar 2024	0%	0%	$6,360,615	541,329	0		$11.75	Q1 2024
31 Dec 2023	0%	-0%	$6,095,364	541,329	-9,251	-1.7%	$11.26	Q4 2023
30 Sep 2023	0%	0%	$3,727,427	550,580	0		$6.77	Q3 2023
30 Jun 2023	0%	+0%	$4,999,266	550,580	+8,937	+1.6%	$9.08	Q2 2023
31 Mar 2023	0%	0%	$3,499,014	541,643	0		$6.46	Q1 2023
31 Dec 2022	0%	0%	$3,434,016	541,643	+245	+0.05%	$6.34	Q4 2022
30 Sep 2022	0%	-0%	$3,357,000	541,398	-12,240	-2.2%	$6.20	Q3 2022
30 Jun 2022	0%	0%	$4,894,000	553,638	0		$8.84	Q2 2022
31 Mar 2022	0%	+0%	$4,661,000	553,638	+42,609	+8.3%	$8.42	Q1 2022
31 Dec 2021	0%	+0%	$5,212,000	511,029	+62,118	+14%	$10.20	Q4 2021
30 Sep 2021	0%	+0%	$8,718,000	448,911	+69,743	+18%	$19.42	Q3 2021
30 Jun 2021	0%	+0%	$6,661,000	379,168	+65,948	+21%	$17.57	Q2 2021
31 Mar 2021	0%	+0%	$3,721,000	313,220	+60,289	+24%	$11.88	Q1 2021
31 Dec 2020	0%	+0%	$4,356,000	252,931	+46,236	+22%	$17.22	Q4 2020
30 Sep 2020	0%	+0%	$2,131,000	206,695	+206,695	NEW	$10.31	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.